Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hypothalamic pathogenesis of type 2 diabetes.

Hiroyuki Koshiyama1, Yoshiyuki Hamamoto, Sachiko Honjo

  • 1Center for Diabetes & Endocrinology, The Tazuke Kofukai Foundation Medical Research Institute, Kitano Hospital, Osaka 530-8480, Japan. h-koshiyama@kitano-hp.or.jp

Medical Hypotheses
|April 18, 2006
PubMed
Summary

Hypothalamic dysregulation is increasingly linked to abnormal glucose metabolism and type 2 diabetes. Understanding the brain-liver circuit and insulin resistance in the hypothalamus may reveal new therapeutic targets.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evaluation of inadvertent stigmatization of individuals with diabetes by healthcare professionals.

Journal of diabetes investigation·2026
Same author

The Efficacy of Imeglimin and Metformin on Insulin Sensitivity and Secretion Using Oral Minimal Model: Sub-Analysis of an Exploratory Randomised Controlled Trial.

Diabetes, obesity & metabolism·2026
Same author

Retrospective comparison of the clinical effects of oral semaglutide and SGLT2 inhibitors treatment in patients with type 2 diabetes.

Journal of diabetes investigation·2026
Same author

Differential impact of COVID-19 on change in body composition in young and older individuals with diabetes in the post-COVID-19 Era.

Journal of diabetes investigation·2025
Same author

Effects of High-Protein Nutritional Guidance on Sarcopenia-Related Parameters in Individuals Aged ≥ 75 Years with Type 2 Diabetes: An Exploratory Single-Arm Pre-Post Intervention Study.

Nutrients·2025
Same author

A multicenter, prospective, real-world study of oral semaglutide in adults with type 2 diabetes in Japanese clinical practice (PIONEER REAL Japan): Subgroup analyses.

Journal of diabetes investigation·2025

Area of Science:

  • Neuroendocrinology
  • Metabolic Diseases
  • Molecular Biology

Background:

  • Growing evidence links hypothalamic dysfunction to abnormal glucose metabolism.
  • Stress-induced hypothalamic-pituitary-adrenal axis overactivity can mimic Cushing's disease, contributing to metabolic disorders.
  • Key molecules like AMP-activated protein kinase are present in both the pancreas and hypothalamus, suggesting integrated metabolic regulation.

Purpose of the Study:

  • To explore the role of the hypothalamus in the pathogenesis of abnormal glucose metabolism and type 2 diabetes.
  • To investigate the brain-liver circuit involving hypothalamic sensing of fuel status and hepatic gluconeogenesis.
  • To examine the contribution of hypothalamic insulin resistance to peripheral insulin resistance.

Main Methods:

Related Experiment Videos

  • Review of experimental and clinical evidence.
  • Analysis of molecular mechanisms involving shared pancreatic-hypothalamic molecules.
  • Examination of mouse models with specific genetic disruptions in hypothalamic insulin signaling.
  • Consideration of recent findings on clock gene regulation in the hypothalamus.

    • Main Results:

    • Hypothalamic dysregulation, including stress responses and altered fuel sensing, is implicated in abnormal glucose metabolism.
    • A brain-liver circuit, influenced by hypothalamic fuel status, modulates hepatic gluconeogenesis.
    • Hypothalamic insulin resistance may drive peripheral insulin resistance, supported by genetic studies in mice.
    • Dysregulation of hypothalamic clock genes is a potential factor in abnormal glucose metabolism.

    Conclusions:

    • Hypothalamic abnormalities are a plausible underlying mechanism for a portion of human type 2 diabetes and insulin resistance.
    • The concept of hypothalamic pathogenesis offers a novel perspective for developing new type 2 diabetes therapies.
    • Targeting hypothalamic pathways presents a promising avenue for future pharmacological interventions in metabolic diseases.